Anti-Thioredoxin / TRX antibody [EPR6111]
- RabMAb
- Recombinant
- KO Validated
- Lab Essentials
- What is this?
Be the first to review this product! Submit a review
|
(8 Publications)
Rabbit Recombinant Monoclonal Thioredoxin / TRX antibody. Suitable for WB and reacts with Human, Mouse, Rat samples. Cited in 8 publications.
View Alternative Names
TRDX, TRX, TRX1, TXN, Thioredoxin, Trx, ATL-derived factor, Surface-associated sulphydryl protein, ADF, SASP
- WB
Lab
Western blot - Anti-Thioredoxin / TRX antibody [EPR6111] (AB109385)
All lanes:
Western blot - Anti-Thioredoxin / TRX antibody [EPR6111] (ab109385) at 1/1000 dilution
Lane 1:
HeLa (Human cervix adenocarcinoma epithelial cell) whole cell lysate at 20 µg
Lane 2:
MCF7 (Human breast adenocarcinoma epithelial cell) whole cell lysate at 20 µg
Lane 3:
NIH/3T3 (Mouse embryonic fibroblast) whole cell lysate at 20 µg
Lane 4:
C2C12 (Mouse myoblasts myoblast) whole cell lysate at 20 µg
Lane 5:
Mouse brain lysate at 20 µg
Lane 6:
PC-12 (Rat adrenal gland pheochromocytoma) whole cell lysate at 20 µg
Lane 7:
C6 (Rat glial tumor glial cell) whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 12 kDa
Observed band size: 12 kDa
false
- WB
Lab
Western blot - Anti-Thioredoxin / TRX antibody [EPR6111] (AB109385)
All lanes:
Western blot - Anti-Thioredoxin / TRX antibody [EPR6111] (ab109385) at 1/1000 dilution
All lanes:
His-tagged human Thioredoxin recombinant protein (aa 1-105)
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 12 kDa
Observed band size: 12 kDa
false
- WB
CiteAb
Western blot - Anti-Thioredoxin / TRX antibody [EPR6111] (AB109385)
Thioredoxin / TRX western blot using anti-Thioredoxin / TRX antibody [EPR6111] ab109385. Publication image and figure legend from Bouitbir, J., Panajatovic, M. V., et al., 2020, Front Pharmacol, PubMed 32792947.
ab109385 was used in this publication in western blot. This may not be the same as the application(s) guaranteed by Abcam. For a full list of applications guaranteed by Abcam for ab109385 please see the product overview.
Antioxidative defenses in C2C12 myotubes and human RD cells. (A) Western blots showing the expression levels of SOD1, SOD2, TRX1, TRX2, and GAPDH in C2C12 myotubes. (B) The graph shows the quantification of protein expression normalized against GAPDH. (C) The mRNA expression of genes involved in the antioxidative defense in RD cells. Data represent the mean ± SEM of three independent experiments. Treatments with TKIs were compared to 0.1% DMSO control with one-way ANOVA followed by Dunnett's post-test. *p < 0.05 versus 0.1% DMSO control. Ima, imatinib; Das, dasatinib; SOD, superoxide dismutase; TRX, thioredoxin.
false
Related conjugates and formulations (1)
-
Anti-Thioredoxin / TRX antibody [EPR6111] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Thioredoxin influences cellular redox homeostasis and plays direct roles in regulating cell growth and apoptosis. It participates as a major reductant in cells influencing transcription factors and enzymatic activities that depend on thiol-disulfide exchanges. Thioredoxin can interact with other components like thioredoxin reductase and NADPH to form the thioredoxin system a powerful antioxidant defense mechanism. Diseases typically arise from abnormal regulation of this system highlighting its influence on cellular survival and proliferation.
Pathways
Thioredoxin integrates into significant signaling and metabolic processes. It is an important player in the cellular response to oxidative stress and participates in signaling pathways such as the MAPK and apoptosis pathways. In these pathways thioredoxin reduces the oxidative stress transcription factor AP-1 influencing cell fate decisions. Its interaction with thioredoxin-interacting protein (TXNIP) further modulates cellular responses to oxidative environments.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (8)
Recent publications for all applications. Explore the full list and refine your search
PloS one 18:e0286903 PubMed37310976
2023
Applications
Unspecified application
Species
Unspecified reactive species
Investigative ophthalmology & visual science 64:16 PubMed36881408
2023
Applications
Unspecified application
Species
Unspecified reactive species
Experimental and therapeutic medicine 25:144 PubMed36911380
2023
Applications
Unspecified application
Species
Unspecified reactive species
BMC cardiovascular disorders 21:603 PubMed34922451
2021
Applications
Unspecified application
Species
Unspecified reactive species
British journal of pharmacology 178:4608-4625 PubMed34265086
2021
Applications
Unspecified application
Species
Unspecified reactive species
Redox biology 46:102065 PubMed34293554
2021
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in pharmacology 11:1106 PubMed32792947
2020
Applications
Unspecified application
Species
Unspecified reactive species
Naunyn-Schmiedeberg's archives of pharmacology 393:991-1002 PubMed31811327
2019
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com